Category: IPO/FPO ANALYSIS
-
Equitas IPO – Leader in SF Banks
Date: 3rd April 2016 IPO price range Rs 109 – 110, Apply from 5-7th Apr 2016 Industry: BFSI – Small Finance Bank Mid Cap: Rs 3,560 cr Mkt Cap Advice: BUY Summary Overview: Equitas Holdings is a financial services firm that has extended beyond microfinance to MSME, CV and housing loans to people that are…
-
Engineers India FPO – A Value BUY
Date – 29th Jan 2016; Issue Period: today, one day only CMP: Rs 194; FPO Floor Pricing: Rs 189/share. Retail gets a 5% discount Mid Cap – Mkt Cap 6500 crores Advice: Investors can BUY with a 2 year perspective Summary Engineers India is a PSU Mini Ratna engaged in providing engineering and technical services and turnkey…
-
Precision Camshafts IPO – an Attractive Finish
Date 26th Jan 2016 Price range: Rs. 180-186 and Period: 27th – 29th Jan 2016 Small Cap – Rs 1750 cr. mkt cap Industry – Auto Ancillary Advice: Investors can BUY with a 2 year perspective Summary Overview: Precision Camshafts is a small auto ancillary firm that makes camshafts. Revenues, EBITDA and PAT have grown by…
-
An IPO Update, Jan 2016
Dear Readers, The IPOs are happening fast and furious, and in this note we recap recent events and try to look ahead too: Alkem Laboratories IPO Our investment report is available on link Alkem Labs IPO Note We had recommended a BUY on Alkem The IPO was open from 8-10th Dec 2015 and Issue Price…
-
Narayana Hrudayalaya IPO – Investors may not be Patient
Date 17th Dec 2015 Price range: Rs. 245-250 and Period: 17-21st Dec 2015 MidCap Rs 5100 cr Mkt Cap Industry – Hospital Services Advice: Avoid Summary Narayana Hrudayalaya Ltd was founded by eminent cardiac surgeon Dr Devi Prasad Shetty in 2000. It operates a national network of hospitals, clinics and primary care facilities. NHL’s revenue…
-
Dr Lal Pathlabs IPO – Essential Services are an Essential Buy
Date 9th Dec 2015 Price range: Rs. 540-550 and application period: 8-10th Dec Industry: Pharma – Diagnostic services Mid Cap – Rs 4550 cr Mkt Cap Advice: Retail Investors can BUY with a 2-3 year perspective Summary Overview: DLP is provider of diagnostic and related healthcare tests and services. DLP’s Revenue, EBITDA and EPS have…
-
Alkem Labs IPO
Dear Reader, The IPO season in India continues with another bunch of offerings planned in December 2015. We have created a new IPO report on Alkem Labs. It is the first large pharma company IPO in over 10 years. Its got a lot going for it. At the same time, the criticism can be on the…
JainMatrix Investments 